Even if women have been taking tamoxifen citrate (Nolvadex tablet, AstraZeneca) for months, they should be observed for symptoms of depression, according to researchers who presented their findings at the American Psychiatric Association’s annual meeting in May 2003. Tamoxifen medication interferes with estrogen activity and is often prescribed for women with advanced and early breast [...]
Prescribing extended-release venlafax-ine rather than generic fluoxetine for depression might be more beneficial to patients in the long term. Researchers from Prescriptions Solutions in Costa Mesa, California, and Wyeth Research in St. Davids, Pennsylvania, found that patients taking ven-lafaxine XR were at least three times more likely to be treated adequately through the crucial first [...]
An estimated five million American working women suffer from depression, and 83% of them perceive it as the number one barrier to success in the workplace, according to a survey sponsored by the American Medical Women’s Association and the National Mental Health Association. The women reported behaviors such as leaving work early or not returning [...]
Teva Pharmaceutical Industries Ltd. has announced final approval of its ANDA for generic paroxetine HCl tablets, 10 mg, 20 mg, 30 mg, and 40 mg. The tablets are the AB-rated generic equivalent of Glaxo-SmithKline’s antidepressant Paxil Tablets.
Ranbaxy Laboratories has received approval to manufacture and market sertraline HCl tablets in base strengths of 25, 50, 100, 150, and 200 mg. The Ranbaxy formulation is bioequiv-alent to, and has the same therapeutic effect as that of, Zoloft generic (Pfizer) tablets in these doses. Sertraline drug is indicated for the treatment of Major Depressive [...]
ABILIFY (Aripiprazole) drug was developed by two companies: Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company. In 2004 Abilify medicine was approved in for treating schizophrenia disease and in 2008 it was ratified as medicine for bipolar disorder. It has been known today that the U.S. Food and Drug Administration (FDA) has accepted for filing [...]
Risperdal drug (Risperidone) is an oral prescription medication that has been approved in the UK for the treatment of mania in bipolar disorder, also known as manic-depression. It causes periods of extreme depression and mania and leads to unusual shifts in a person’s energy, mood and ability to function. This chronic illness needs to be [...]
